In the pharma entity “PCD” would mean “Propaganda Cum Distribution“. In this model, a pharmaceutical company can carry out a sublicensing process, passing a distribution license to a physical person or legal entity for distribution of its products only in a pre-specified locality or area. The phrase “propaganda” used here refers to the marketing efforts carried out by pharmaceutical companies to create awareness about their products, mainly for professional caretakers and consumers. So, PCD covers the promotion aspect as well as the distribution of medicines in the pharmacy business.
PCD in Pharma:
Understanding the Decisions About Drugs and Pharmaceutical Corporations, PCD is known and widely working in the field of distribution and marketing of pharmaceutical products. These types of businesses have their style of business process. Pharmaceutical industries sub-license distribution rights to traders or individuals called retailers at certain geographical areas or locations. Then, these franchising market owners use their resources to designate the specific region where they will sell the company’s products.
Frequently Asked Questions (FAQ) About PCD in Pharma
PCD stands for “Propaganda Cum Distribution.
In the pharmaceutical industry, PCD refers to a business model where companies grant distribution rights to individuals or entities, allowing them to distribute pharmaceutical products within a specified region.
The term “propaganda” in this context refers to promotional activities aimed at spreading awareness about pharmaceutical products, while “cum” is Latin for “with” or “and,” indicating the dual role of marketing and distribution.
Under the PCD model, pharmaceutical companies appoint franchisees who are responsible for distributing the company’s products in designated geographic areas. These franchisees often undertake promotional activities as well.
The PCD model, in pharmaceutical companies, aids them in expanding their market reach with no significant capital investment. It promotes entering diverse geographic areas via the local knowledge and networks of franchisees which, in turn, will boost the company’s production.
PCD franchises benefit from established brand recognition, product portfolio, and marketing support from the parent company. They also gain access to a ready-made distribution network.
Unlike traditional distribution models where companies directly handle distribution, the PCD model involves granting distribution rights to independent franchisees.
Promotional activities are the cornerstone of the PCD model since they help to bring about product awareness among healthcare professionals and consumers who rely on the same for the easy marketing of pharmaceutical products.
Yes, agreements on franking and marketing activities that are done under the PCD model are subject to the supervision of regulatory acts in the pharmaceutical sphere that control the observance of pharmaceutical laws and regulations.
Yes, the enterprises and persons interested in opening PCD franchisees rather can use the chance to apply for it directly through a pharmaceutical company or its official channel.